Studies related to vLDL-C and Spirulina

Hypocholesterolemic Effect Of Spirulina In Patients With Hyperlipidemic Nephrotic Syndrome

Effect Decrease
Values Mean and SD. mg/dl Control: before 26.05 ± 10.23, after 107.75 ± 64.27. Spirulina: before 227.98 ± 121.0, after 160.26 ± 121.99.
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 23
Sex Both Genders
Age Range 1-6, 7-12
Notes for this study:
In a 2-month randomized trial, 23 children with nephrotic syndrome took 1 g/d of spirulina with medication or only medication.

Weight, BMI, and waist-hip ratio weren't different.

The spirulina group saw a statistically significant reduction (compared with baseline) in triglycerides and VLDL-C, while the reduction in the control group was nonsignificant. Fasting glucose, total cholesterol, and LDL were reduced more in the spirulina group, but either the difference compared with baseline wasn't statistically significant, or the reduction in the control group was also statistically significant. HDL was reduced a little more in the control group, but the reduction wasn't significant.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.